SLAS Discovery, Volume 26, December 2021
"A diverse range of biochemical and cellular assays are used by medicinal chemists to guide compound optimization. The data collected from these assays influence decisions taken on structure-activity relationship (SAR) campaigns. Therefore, it is paramount that medicinal chemists have a solid understanding of the strengths and limitations of each assay being used to characterize synthesized analogs.
This Perspective Article takes a look at assays relevant to Gaucher, Pompei, Wolman, and Fabry disease, Duchenne muscular dystrophy, and Cystic Fibrosis."
Elsevier, Current Developments in Nutrition, Volume 5, 1 December 2021
This study explores the pathways from a nutrition-sensitive agriculture intervention to improved diets of women and young children. It also tests theoretical agriculture-to-nutrition pathways by comparing the authors' documented pathways with the pathways from the widely used TANDI (Tackling the Agriculture–Nutrition Disconnect in India) framework.
Current Research in Microbial Sciences, Volume 2, December 2021
Fluorescent and non-fluorescent species of Pseudomonas are important for plant growth promotion, phytopathogenic control and plant disease management. Ecologically significant applications of Pseudomonas in biocontrol and bioaugmentation are crucial for maintaining food security.
Current Research in Microbial Sciences, Volume 2, December 2021
In this review, we explore how agriculture is implementing the use of microbial inoculants (single species or consortia) to improve crop yields, and discuss current strategies to study plant-associated microorganisms and how their diversity varies under unconventional agriculture.
Current Research in Microbial Sciences, Volume 2, December 2021
African swine fever outbreak has caused serious economic losses in China. Consequently, pork supply faces huge demand. An effective biosafety procedure was developed for production of pigs in small-scale farms in China.
Elsevier, The Lancet, Volume 398, 6 November 2021
An Article on the impact of the COVID-19 pandemic on the global prevalence of depressive and anxiety disorders in 2020, in the context of SDG 3, highlighting the need for mitigation strategies to promote mental wellbeing and target determinants of poor mental health.
